Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-062079
Filing Date
2019-11-12
Accepted
2019-11-12 08:01:50
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919558d1_10q.htm 10-Q 913308
2 EXHIBIT 31.1 tm1919558d1_ex31-1.htm EX-31.1 12638
3 EXHIBIT 31.2 tm1919558d1_ex31-2.htm EX-31.2 12661
4 EXHIBIT 32.1 tm1919558d1_ex32-1.htm EX-32.1 5545
5 EXHIBIT 32.2 tm1919558d1_ex32-2.htm EX-32.2 5607
  Complete submission text file 0001104659-19-062079.txt   5564932

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mbio-20190930.xml EX-101.INS 1328958
7 XBRL TAXONOMY EXTENSION SCHEMA mbio-20190930.xsd EX-101.SCH 44108
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbio-20190930_cal.xml EX-101.CAL 48301
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbio-20190930_def.xml EX-101.DEF 211259
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20190930_lab.xml EX-101.LAB 364500
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20190930_pre.xml EX-101.PRE 335667
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 191206231
SIC: 2834 Pharmaceutical Preparations